Invicro

The vast majority of the RLT companies conducting clinical translation have relied on Invicro’s scientific collaboration to bring their molecules to an IND. Meet with Invicro's @SeanCarlin at #TRPSummit to discover how our pioneering approach to radioligand therapy development accelerates the path to human trials and seamlessly integrates with the existing clinical #RLT ecosystem: https://hubs.ly/Q02GWNjn0 #radiopharmaceuticals #theranostics #NuclearMedicine #MolecularImaging

Whether you’re dealing with complex medical imaging challenges or managing diverse datasets, Invicro has you covered. Our Advanced Special Projects (ASP) team offers bespoke AI/ML solutions, and our software image analysis (SWIA) offerings provide tailored solutions designed to meet specific analytical needs using your existing datasets. Get in touch with our team to discover how our integrated approach can elevate your research: https://hubs.ly/Q02GKlX90

We look forward to seeing you during #AAIC24 in Philadelphia from July 28 to August 1. CALYX/Invicro have been pioneers in #AlzheimersResearch for over two decades, providing support in the majority of the most critical #AlzheimersTrials over the past ten years. Stop by booth #921 and learn how we empower #Alzheimer's disease research with our extensive experience across preclinical, early-phase, and late-phase clinical studies. Trust your pivotal trials with our scientific and operational experts, who can proactively address challenges before they arise. Let's connect: https://hubs.ly/Q02GjdVW0 #AAIC2024

Invicro is thrilled to see a significant step forward with CMS's proposed changes to the Hospital Outpatient Prospective Payment System (OPPS) for 2025! For too long, diagnostic radiopharmaceuticals have been bundled into overall payment systems, often leading to underfunding for these critical tools. By recognizing the unique value and cost of advanced diagnostics, CMS is paving the way for greater accessibility and utilization of cutting-edge nuclear medicine procedures. This change is a monumental leap forward for patients who depend on accurate, timely diagnoses. #radiopharmaceuticals #RLT

Did you know that reproducible and time-efficient criteria based on FDG-PET imaging have led to improved clinical outcomes in the development of new cancer therapies for FDG-avid lymphoma? Join a panel of experts as they discuss the evolution of imaging-based response criteria for lymphomas, challenges in developing a standardized operational reader workflow for clinical trials, and operational recommendations for radiologists using lymphoma response assessment criteria. Don't miss out on this informative discussion! https://hubs.ly/Q02DZzdG0 #PET #lymphoma #oncology #imagingCRO

We’re excited to attend the 3rd Annual Targeted Radiopharmaceuticals (TRP) Summit on July 30-August 1 in San Diego! While radioligand therapies have gained significant traction in recent years, Invicro has been dedicated to nuclear medicine for over two decades, leading the forefront of the radiopharmaceutical boom. Your preclinical and clinical trials need Invicro as your scientific and operational collaborator. Let’s meet to discuss your RLT programs: https://hubs.ly/Q02G0_PV0 #TRPsummit #theranostics #radiopharmaceuticals #nuclearmedicine #molecularimaging

Invicro's Software and Image Analysis (SWIA) team excels in managing a variety of imaging formats and applications to enhance your understanding of imaging biomarkers. Our customized approach seamlessly integrates with your data to provide insightful, precise analyses. Ready to elevate your research? Get in touch: https://hubs.ly/Q02D1cp10

The development and optimization of novel radioligands for drug development applications is critical to move new compounds from bench to bedside. Join Lisa Wells, PhD as she provides an overview of a typical study design for the development of a suitable PET radioligand for a novel target in CNS disease models. She explains the importance of determining target expression in the tissue(s) of interest and candidate ligand characteristics prior to in vivo imaging and explores how data is analyzed in preclinical animal models, non-human primates and human subjects. https://bit.ly/4cIu4ch #PET #SPECT #CNS #radioligand

Happy Independence Day from Invicro! May your July 4th be full of #freedom, #family & #fun! #July4th #IndependenceDay2024

Congratulations Eli Lilly and Company! As a leader in the field of imaging in #Alzheimer’s disease, we celebrate this incredible milestone for the patients living with AD, their families and the research community.